Diabetes-Obstructive Sleep Apnea Treatment Trial

Stopped early · Not applicable · Has a placebo group

Conditions studied: Type 2 Diabetes, Obstructive Sleep Apnea

In brief

Diabetes self-management is important to help adults with type 2 diabetes achieve glucose control. Obstructive sleep apnea often co-exists with type 2 diabetes and may act as a barrier to diabetes self-management and glucose control. We will examine if treatment of obstructive sleep apnea with continuous positive airway pressure (CPAP), combined with diabetes education, results in improved diabetes self-management and glucose control.

Key facts

Study ID

NCT01901055

Run by

Eileen R. Chasens

People needed

98

Starts

2014-02-13

Expected to finish

2019-05-08

Last updated by the study team

2021-08-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Suboptimal glucose control (A1C ≥ 6.5%)
• Moderate-to-severe obstructive sleep apnea (apnea + hypopnea index >= 10/hour)
• age 18 years and older

You may not qualify if…

• Poor glucose control (A1C > 11)
• Type 1 or gestational diabetes
• Sleep duration < 4 hrs
• Acute medical or surgical conditions or hospitalization ≤ 3 months
• Oxygen or bi-level PAP required
• Prior CPAP or persons in household with CPAP
• Employed in safety sensitive job
• Pregnant

Where it is running

• John D. Dingell VAMC — Detroit, Michigan, United States
• Pittsburgh Veterans Administration Medical Center — Pittsburgh, Pennsylvania, United States
• University of Pittsburgh — Pittsburgh, Pennsylvania, United States
• West Virginia University — Morgantown, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.